| Gene symbol | CD70 | Synonyms | CD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.3 | dbXrefs | |
| Description | CD70 molecule | ||||
| GTO ID | GTC3923 |
| Trial ID | NCT06480565 |
| Disease | Clear Cell Renal Cell Carcinoma |
| Altered gene | CD70 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ADI-270 |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | A Phase 1/2 Trial of ADI-270 (Engineered γδ Chimeric Receptor [CAR] Vδ1 T Cells Targeting CD70) in Adults With Relapsed or Refractory (R/R) Clear Cell Renal Cell Carcinoma (ccRCC) |
| Year | 2024 |
| Country | United States |
| Company sponsor | Adicet Therapeutics |
| Other ID(s) | ADI-202427001 |
| Cohort 1 | |||||||||
|
|||||||||